Hidenori Ando

2.1k total citations · 1 hit paper
83 papers, 1.7k citations indexed

About

Hidenori Ando is a scholar working on Molecular Biology, Immunology and Biomaterials. According to data from OpenAlex, Hidenori Ando has authored 83 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 27 papers in Immunology and 20 papers in Biomaterials. Recurrent topics in Hidenori Ando's work include RNA Interference and Gene Delivery (31 papers), Immunotherapy and Immune Responses (22 papers) and Nanoparticle-Based Drug Delivery (19 papers). Hidenori Ando is often cited by papers focused on RNA Interference and Gene Delivery (31 papers), Immunotherapy and Immune Responses (22 papers) and Nanoparticle-Based Drug Delivery (19 papers). Hidenori Ando collaborates with scholars based in Japan, Egypt and Saudi Arabia. Hidenori Ando's co-authors include Tatsuhiro Ishida, Taro Shimizu, Yu Ishima, Sherif E. Emam, Amr S. Abu Lila, Nehal E. Elsadek, Hatem A. Sarhan, Masami Ukawa, Tomohiro Asai and Naoto Oku and has published in prestigious journals such as Advanced Drug Delivery Reviews, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Hidenori Ando

80 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products

2022 286 citations Eslam Ramadan, Nehal E. Elsadek et al. Journal of Controlled Release profile →

Peers

Hidenori Ando

BIOMA

IMMUN

Zhirong Zhong China

Shuang Cai China

Meng Zhou China

Ye Liang China

Pengxuan Zhao China

Xin Wei United States

Leaf Huang United States

Nina Filipczak United States

Raúl Ortíz Spain

Satya Siva Kishan Yalamarty United States

Zhirong Zhong China

Hidenori Ando

766 ×0.8

345 ×0.7

BIOMA

350 ×1.1

199 ×0.8

IMMUN

146 ×0.6

Citations per year, relative to Hidenori Ando Hidenori Ando (= 1×) peers Zhirong Zhong

Countries citing papers authored by Hidenori Ando

Since Specialization

Citations

This map shows the geographic impact of Hidenori Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidenori Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidenori Ando more than expected).

Fields of papers citing papers by Hidenori Ando

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidenori Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidenori Ando. The network helps show where Hidenori Ando may publish in the future.

Co-authorship network of co-authors of Hidenori Ando

This figure shows the co-authorship network connecting the top 25 collaborators of Hidenori Ando. A scholar is included among the top collaborators of Hidenori Ando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidenori Ando. Hidenori Ando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shimizu, Taro, et al.. (2025). An in vitro nanocarrier-based B cell antigen loading system; tumor growth suppression via transfusion of the antigen-loaded B cells in vivo. International Journal of Pharmaceutics. 670. 125189–125189.

Shimizu, Taro, Amr S. Abu Lila, Ryo Abe, et al.. (2024). Peritoneal B Cells Play a Role in the Production of Anti-polyethylene Glycol (PEG) IgM against Intravenously Injected siRNA-PEGylated Liposome Complexes. Biological and Pharmaceutical Bulletin. 47(2). 469–477. 2 indexed citations

Fujiwara, Masashi, Hidenori Ando, Yasushi Sato, et al.. (2024). Application of bacterial-derived long cellulose nanofiber to suspension culture of mammalian cells as a shear protectant. International Journal of Biological Macromolecules. 280(Pt 3). 135938–135938. 1 indexed citations

Shimizu, Taro, Hidenori Ando, Naoto Okada, et al.. (2024). Humoral immune response against SARS-CoV-2 and polyethylene glycol elicited by anti-SARS-CoV-2 mRNA vaccine, and effect of pre-existing anti-polyethylene glycol antibody in patients with hematological and autoimmune diseases. Heliyon. 10(10). e31489–e31489. 2 indexed citations

Shimizu, Taro, Nehal E. Elsadek, Sherif E. Emam, et al.. (2023). Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route. Journal of Controlled Release. 360. 285–292. 22 indexed citations

Ando, Hidenori, Kiyoshi Eshima, & Tatsuhiro Ishida. (2023). A polyethylene glycol-conjugate of deoxycytidine analog, DFP-14927, produces potential antitumor effects on pancreatic tumor-xenograft murine models via inducing G2/M arrest. European Journal of Pharmacology. 950. 175758–175758. 1 indexed citations

Shimizu, Taro, Hidenori Ando, Sherif E. Emam, et al.. (2023). Treatment-induced and Pre-existing Anti-peg Antibodies: Prevalence, Clinical Implications, and Future Perspectives. Journal of Pharmaceutical Sciences. 113(3). 555–578. 24 indexed citations

Shimizu, Taro, Amr S. Abu Lila, Nehal E. Elsadek, et al.. (2022). A mouse model for studying the effect of blood anti-PEG IgMs levels on the in vivo fate of PEGylated liposomes. International Journal of Pharmaceutics. 615. 121539–121539. 12 indexed citations

Kinoshita, Ryo, Yu Ishima, Victor Tuan Giam Chuang, et al.. (2021). The Therapeutic Effect of Human Serum Albumin Dimer-Doxorubicin Complex against Human Pancreatic Tumors. Pharmaceutics. 13(8). 1209–1209. 8 indexed citations

10.

Ando, Hidenori, Amr S. Abu Lila, Kenji Tajima, et al.. (2021). Doxorubicin Embedded into Nanofibrillated Bacterial Cellulose (NFBC) Produces a Promising Therapeutic Outcome for Peritoneally Metastatic Gastric Cancer in Mice Models via Intraperitoneal Direct Injection. Nanomaterials. 11(7). 1697–1697. 10 indexed citations

11.

Ando, Hidenori, Amr S. Abu Lila, Noriyuki Maeda, et al.. (2021). I.p.-injected cationic liposomes are retained and accumulate in peritoneally disseminated tumors. Journal of Controlled Release. 341. 524–532. 12 indexed citations

12.

Shimizu, Taro, et al.. (2021). Nucleic acids delivered by PEGylated cationic liposomes in systemic lupus erythematosus-prone mice: A possible exacerbation of lupus nephritis in the presence of pre-existing anti-nucleic acid antibodies. International Journal of Pharmaceutics. 601. 120529–120529. 9 indexed citations

13.

Shimizu, Taro, Amr S. Abu Lila, Yuki Kanazawa, et al.. (2020). Adjuvant Antitumor Immunity Contributes to the Overall Antitumor Effect of Pegylated Liposomal Doxorubicin (Doxil®) in C26 Tumor-Bearing Immunocompetent Mice. Pharmaceutics. 12(10). 990–990. 8 indexed citations

14.

Ando, Hidenori, Amr S. Abu Lila, Taro Shimizu, et al.. (2020). A Unique Gene-Silencing Approach, Using an Intelligent RNA Expression Device (iRed), Results in Minimal Immune Stimulation When Given by Local Intrapleural Injection in Malignant Pleural Mesothelioma. Molecules. 25(7). 1725–1725. 2 indexed citations

15.

Ikeda, Mayumi, Yu Ishima, Victor Tuan Giam Chuang, et al.. (2019). Distribution of Polysulfide in Human Biological Fluids and Their Association with Amylase and Sperm Activities. Molecules. 24(9). 1689–1689. 21 indexed citations

16.

Emam, Sherif E., Amr S. Abu Lila, Nehal E. Elsadek, et al.. (2019). Cancer cell-type tropism is one of crucial determinants for the efficient systemic delivery of cancer cell-derived exosomes to tumor tissues. European Journal of Pharmaceutics and Biopharmaceutics. 145. 27–34. 65 indexed citations

17.

Emam, Sherif E., Hidenori Ando, Amr S. Abu Lila, et al.. (2018). Liposome co-incubation with cancer cells secreted exosomes (extracellular vesicles) with different proteins expressions and different uptake pathways. Scientific Reports. 8(1). 14493–14493. 35 indexed citations

18.

Lila, Amr S. Abu, et al.. (2017). Ganglioside inserted into PEGylated liposome attenuates anti-PEG immunity. Journal of Controlled Release. 250. 20–26. 47 indexed citations

19.

Ando, Hidenori, Amr S. Abu Lila, Taro Shimizu, et al.. (2017). Reactivity of IgM antibodies elicited by PEGylated liposomes or PEGylated lipoplexes against auto and foreign antigens. Journal of Controlled Release. 270. 114–119. 14 indexed citations

20.

Nakamura, Hiroyuki, Amr S. Abu Lila, Masao Tanaka, et al.. (2015). Intra-tumor distribution of PEGylated liposome upon repeated injection: No possession by prior dose. Journal of Controlled Release. 220(Pt A). 406–413. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact